- Use of Gabapentin in the treatment of neuropathic
pain -
Dr. Gareth Parry
Published in the sept. 2005 newsletter of the GBS
Support Group of New Zealand
Gabapentin, (trade name, Neurontin) has been approved by the Federal
Drug Administration in the United States for the treatment of some
forms of neuropathic pain. Research studies have shown that it is
beneficial in post-herpetic neuralgia (the pain that occurs after
an attack of shingles) and in painful diabetic neuropathy. Clinical
experience indicates that it is also helpful in many other forms of
neuropathic pain, including the pain that occurs following an attack
of Guillain-Barré syndrome (GBS) and with chronic inflammatory
demyelinating polyneuropathy (CIDP). The lowest possible dose should
be used but effective doses are usually between 1800 and 2400 mg daily,
in divided doses. Doses of up to 3600 mg daily have sometimes been
used with good effect.
Gabapentin is not an effective treatment of normal
physiological pain; i.e. the pain that occurs with things like a broken
leg or with appendicitis. It only works for neuropathic pain, the
pain that results from damage to nerves. When nerves are damaged,
abnormal electrical discharges develop that are perceived by the brain
as pain. Gabapentin improves neuropathic pain by reducing these abnormal
electrical discharges. It does so by partially blocking a specific
channel in the nerves that is necessary for these abnormal discharges
to reach the brain.
Gabapentin is generally a well tolerated and safe
medication. About 20% of patients will experience some sleepiness
and dizziness but both symptoms usually get less severe even with
continued treatment. About 5% of patients will develop swelling of
the feet and ankles but this is usually mild and does not require
treatment and does not usually necessitate stopping the drug.
Gabapentin should be started as a low dose, generally
300 mg once a day although in the elderly the starting dose may need
to be as low as 100 mg daily. The dose can then be slowly increased
until benefit is felt. Complete loss of pain is extremely unlikely.
The goal is to reduce the pain and improve sleep and other aspects
of quality of life. Once very important advantage of Gabapentin is
that it does not interact with other medications.
Gabapentin is an expensive medication but it has recently
lost its patent protection. This usually results in a significant
reduction in cost and may make the drug more widely available to the
New Zealand consumer.
Use of this website signifies an acceptance of the
Terms of Use. No responsibility is taken for any errors, omissions
or misinterpretations. These pages should be used for information
only and you are strongly advised to seek professional help particular
to your circumstances. © Copyright 2001-2007.